Showing results (231-240 of 392) with videos related to

Sort By:
Pageof 40
Archives of Biochemistry and Biophysics|October 15, 1996
Effect of secondary structure on the activity of enzymes suspended in organic solventsA Dong, J D Meyer, B S Kendrick, et al.
Journal of Pharmaceutical Sciences|May 24, 2007
Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvantsChristina Vessely, Tia Estey, Theodore W Randolph, et al.
Journal of Pharmaceutical Sciences|June 8, 2012
Physical stability of albinterferon-α(2b) in aqueous solution: effects of conformational stability and colloidal stability on aggregationDanny K Chou, Rajesh Krishnamurthy, Mark Cornell Manning, et al.
Journal of Pharmaceutical Sciences|April 17, 2021
Subvisible Particles in Solutions of Remicade in Intravenous Saline Activate Immune System Pathways in In Vitro Human Cell SystemsNeha N Pardeshi, Maryam Ahmadi, Izabela Sierzputowska, et al.
Biochimica Et Biophysica Acta|March 14, 2009
Role of electrostatic repulsion on colloidal stability of Bacillus halmapalus alpha-amylaseSøren N Olsen, Kim B Andersen, Ted W Randolph, et al.
Journal of Pharmaceutical Sciences|August 19, 2014
Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administrationMerry Christie, Raul M Torres, Ross M Kedl, et al.
Archives of Biochemistry and Biophysics|December 31, 1997
Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solutionA Dong, B Kendrick, L Kreilgârd, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 13, 2023
Physical Compatibility of Y-site Pediatric Drug Administration: A Call for Question of US Pharmacopeia StandardsEmma L Ross, Kirsten Petty, Allison Salinas, et al.
Journal of Pharmaceutical Sciences|December 1, 2004
Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulationEva Y Chi, Joachim Weickmann, John F Carpenter, et al.
Pageof 40